Pembrolizumab First-Line HNSCC Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Pembrolizumab First-Line HNSCC
Head and Neck Squamous Cell Carcinoma (HNSCC) is a type of cancer that begins in the moist tissues lining the head and neck, such as the mouth, throat, voice box, and sinuses. It's a serious condition that requires prompt and effective treatment. "First-line pembrolizumab" refers to the use of the immunotherapy drug pembrolizumab (brand name Keytruda) as the initial treatment for certain advanced H
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.